Mechanistic Investigation of Xuebijing for Treatment of Paraquat-Induced Pulmonary Fibrosis by Metabolomics and Network Pharmacology

Tongtong Wang,Sha Li,Yangke Wu,Xiao Yan,Yiming Zhu,Yu Jiang,Feiya Jiang,Wen Liu
DOI: https://doi.org/10.1021/acsomega.1c02370
IF: 4.1
2021-07-20
ACS Omega
Abstract:After paraquat (PQ) poisoning, it is difficult to accurately diagnose patients' condition by only measuring their blood PQ concentration. Therefore, it is important to establish an accurate method to assist in the diagnosis of PQ poisoning, especially in the early stages. In this study, a gas chromatography–mass spectrometry (GC–MS) metabonomics strategy was established to obtain metabolite information. A random forest algorithm was used to search for potential biomarkers of PQ poisoning, and data mining and network pharmacological analysis were used to evaluate the active components, drug–disease targets, and key pathways of Xuebijing (XBJ) injection in the treatment of PQ-induced pulmonary fibrosis. Targets from the network pharmacology analysis and metabolites from plasma metabolomics were jointly analyzed to select crucial metabolic pathways. Finally, molecular docking technology and in vitro experiments were used to verify the pathway targets to further reveal the potential mechanisms underlying the antipulmonary fibrosis effect of XBJ. Metabonomics studies showed that l-valine, glycine, citric acid, d-mannose, d-galactose, maltose, l-tryptophan, and arachidonic acid contributed more to the differentiation of different groups than other metabolites. Compared with the control group, the PQ poisoning group had higher levels of l-valine, glycine, citric acid, l-tryptophan, and arachidonic acid, and lower levels of d-mannose, d-galactose, and maltose. After treatment with XBJ injection, the relative levels of these metabolites were reversed. The network pharmacological analysis screened a total of 180 targets, mainly involving multiple signaling pathways and metabolic pathways, which jointly played an antipulmonary fibrosis effect. Based on the combined analysis of 180 targets and 8 different metabolites, arachidonic acid metabolism was selected as the key metabolic pathway. Molecular docking analysis showed that the XBJ compound had strong binding activity with the target protein. Western blot results showed that XBJ injection could reduce the inflammatory response by downregulating the expressions of p-p65, p-IKBα, and p-IKKβ, thus inhibiting the development of PQ-induced pulmonary fibrosis. In summary, the combined results from metabolomics and network pharmacology studies showed that Xuebijing has the characteristics of multitarget, multichannel, and multicomponent action in the treatment of pulmonary fibrosis caused by PQ.This article has not yet been cited by other publications.
chemistry, multidisciplinary
What problem does this paper attempt to address?
### Problems the Paper Attempts to Solve This paper aims to investigate the mechanisms of Xuebijing (XBJ) injection in treating paraquat (PQ)-induced pulmonary fibrosis through metabolomics and network pharmacology approaches. Specifically: 1. **Early Diagnostic Methods**: - After paraquat poisoning, it is difficult to accurately diagnose the patient's condition solely based on the concentration of paraquat in the blood. Therefore, establishing an accurate method to assist in the early diagnosis of paraquat poisoning is very important. 2. **Metabolite Information Acquisition**: - Researchers used a gas chromatography-mass spectrometry (GC-MS) metabolomics strategy to obtain metabolite information and employed a random forest algorithm to screen for potential biomarkers. 3. **Mechanism of Xuebijing**: - Through data mining and network pharmacology analysis, the study evaluates the active components, drug-disease targets, and key pathways of Xuebijing in treating paraquat-induced pulmonary fibrosis. By jointly analyzing the active components of Xuebijing and plasma metabolomics data, key metabolic pathways are screened, and these pathway targets are validated through molecular docking techniques and in vitro experiments, revealing the potential mechanisms of Xuebijing's anti-pulmonary fibrosis effects. ### Key Findings - Metabolomics studies indicate that L-valine, glycine, citric acid, D-mannose, D-galactose, maltose, L-tryptophan, and arachidonic acid show significant differences between different groups. - After Xuebijing treatment, the relative levels of these metabolites were reversed. - Network pharmacology analysis identified 180 targets, mainly involving various signaling pathways and metabolic pathways, collectively exerting anti-pulmonary fibrosis effects. - Arachidonic acid metabolism was selected as a key metabolic pathway, and Xuebijing demonstrated significant effects in treating pulmonary fibrosis with its multi-target, multi-channel, and multi-component characteristics.